What is the difference between GMP, Kostak Rate, and Subject to Sauda?

GMP is the per-share premium expected at listing. Kostak Rate is a fixed cash amount paid to buy an IPO application irrespective of whether the application is allotted shares or not (hedging allotment risk). Subject to Sauda (SS) is a conditional deal where the premium is payable only if shares are actually allotted to the application.

How is profit made on IPO listing day taxed in India?

If an investor flips allotted IPO shares on listing day or within 12 months of allotment, the profit is classified as Short-Term Capital Gains (STCG) under Section 111A of the Income Tax Act 1961. Following the Union Budget 2024 amendments, STCG on listed equity shares is taxed at a flat rate of 20% (plus applicable surcharge and 4% cess).

Can GMP be artificially manipulated before an IPO closes?

Yes. Because the grey market operates outside SEBI oversight without electronic clearing corporations or formal order books, cartel operators and syndicate brokers can circulate circular quotes or fake bid levels to inflate GMP, creating artificial FOMO (fear of missing out) to drive up retail subscription figures.

IPO Grey Market Premium (GMP) Explained: Real Listing Gain Calculator, Kostak Rate & Risk Guide

Q: What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is the unofficial, over-the-counter cash premium that traders and institutional operators are willing to pay per share above the official IPO issue price prior to the stock being listed on the NSE and BSE. It reflects informal retail and high-net-worth demand, though it carries zero statutory guarantee.

Read in Your Regional Language:

Select your preferred Indian language to automatically translate this full forecast and page.

Quick Answer & Key Takeaways

What is IPO Grey Market Premium (GMP) and how does it predict listing day gains?

IPO Grey Market Premium (GMP) is an unregulated, over-the-counter cash premium traded between dealers and investors prior to an IPO's official listing on the stock exchange. Expected listing price is calculated by adding the GMP to the IPO issue price (Issue Price + GMP = Estimated Listing Price). While GMP provides an accurate gauge of market euphoria and institutional demand for heavily subscribed issues, it carries zero statutory guarantee, is prone to operator manipulation to induce retail subscriptions, and gains on listing day are subject to 20% Short-Term Capital Gains (STCG) tax under Section 111A.

Interactive Financial Model

IPO Listing Gain, Net Tax & Kostak Arbitrage Calculator

Simulate expected listing prices, gross dollar gains, Section 111A taxes, and Kostak hedging profits.

IPO Issue Price (₹)

₹

Grey Market Premium (GMP ₹)

₹

Lot Size (Shares/Lot)

Lots Allotted

Kostak Rate Offered per Application (₹)Hedging Allotment Risk

₹

Statutory Risk Notice

Grey market transactions are unofficial cash contracts without SEBI or stock exchange recognition. High GMP can evaporate overnight upon negative macroeconomic news or market corrections.

Listing Day Projection+35% Projected Gain

Expected Listing Price₹675Issue: ₹500 + GMP: ₹175

Gross Profit (30 shares)₹5,250₹5250 per lot

Total Capital Outlay (at Allotment):₹15,000

Expected Total Portfolio Value:₹20,250

Section 111A STCG Tax (20% + 4% Cess):-₹1,092

Net Post-Tax Profit in Hand:₹4,158

Guaranteed Kostak Return (Zero Allotment Risk):₹450

Selling on Kostak locks in ₹450/lot in cash whether you receive allotment or not, whereas holding for listing yields ₹4158 only if the issue is allotted and GMP sustains.

* Calculations include revised Section 111A rates (effective FY 2024-25 onwards). Grey market figures are illustrative and unregulated.

The Anatomy of the Grey Market: GMP, Kostak & Subject to Sauda

The IPO grey market functions across informal financial syndicates primarily located in Rajkot, Mumbai, Ahmedabad, and Jaipur. Understanding the three primary transaction structures is vital to navigating this space:

Grey Market Premium (GMP)

Per Share Premium

The premium value quoted on an individual share. If an issue is priced at ₹500 and the GMP is ₹150, buyers are willing to buy the stock at ₹650 on listing morning.

Kostak Rate

Per Application Sale

A flat cash fee paid to the applicant upon submitting their IPO form. The buyer receives the listing profit if allotted, but the seller keeps the Kostak cash even if zero shares are allotted.

Subject to Sauda (SS)

Conditional Allotment Deal

A lump-sum contract valid only upon confirmed share allotment. If you are allotted 1 lot, you receive the full agreed premium (e.g. ₹5,000); if not allotted, the deal is cancelled.

Taxation of IPO Listing Gains: Section 111A Post-Budget 2024

Profits realized from flipping IPO shares on the listing date are subject to rigorous statutory taxation under the Income Tax Act 1961:

Short-Term Capital Gains (STCG) at Flat 20%

Under Section 111A, shares held for less than 12 months from the date of allotment and sold via the stock exchange (attracting STT) are taxed at a flat 20% rate (hiked from the previous 15% in the Union Budget 2024). A 4% Health and Education Cess brings the effective tax rate to 20.8%.

Unregistered Cash Kostak / GMP Income

Unofficial cash received in grey market settlements outside banking channels constitutes undisclosed income under Section 68 / 69A of the Income Tax Act, taxable at an punitive 78% rate (60% tax + 25% surcharge + 4% cess) with strict non-deductibility of expenses.

The 4 Major Pitfalls of Relying Exclusively on GMP

Investors should never treat GMP as an infallible indicator of company fundamentals:

Operator Circular Quotes & Artificial Volume

Syndicate promoters can inflate grey market bids with zero intent of execution simply to generate high headline GMP, prompting retail investors to oversubscribe weak SME or mainboard offerings.

Counterparty Settlement Default Risk

Since transactions are bilateral and unbacked by clearing corporations, dealers frequently renege or default on payment if an IPO opens at a catastrophic discount to expected premiums.

Market Sentiment Sensitivity (T+3 Cycle Shock)

Even with T+3 expedited listing cycles, global market shocks, geopolitical escalations, or domestic interest rate announcements during the waiting window can wipe out 100% of GMP prior to bell ringing.

Ignored Valuation Anchors (P/E & EV/EBITDA Disregard)

A high GMP does not validate overpriced issues where existing venture capital or private equity investors are offloading secondary Offer for Sale (OFS) shares at unsustainable multiples.